GENELUX CORPORATION Shareholders' Equity
GENELUX CORPORATION (GNLX) had Shareholders' Equity of $16.11 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $16.11M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $22.92M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $11.54M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $18.59M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $16.11M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $22.92M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $11.54M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $18.59M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $23.90M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $29.85M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $26.27M 10-Q · filed 2026-08-13 |
| 2024-09-30 | $33.09M 10-Q · filed 2025-11-05 |
| 2024-06-30 | $37.67M 10-Q · filed 2025-11-05 |
| 2024-03-31 | $15.08M 10-Q · filed 2025-11-05 |
| 2023-12-31 | $19.47M 10-K · filed 2026-03-19 |
| 2023-09-30 | $24.03M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $22.26M 10-Q · filed 2024-11-14 |
| 2023-03-31 | $2.69M 10-Q · filed 2024-08-14 |
| 2022-12-31 | -$35.78M 10-K · filed 2025-03-28 |
| 2022-09-30 | -$32.33M 10-Q · filed 2023-11-14 |
| 2022-06-30 | -$39.06M 10-Q · filed 2023-11-14 |
| 2022-03-31 | -$36.54M 10-Q · filed 2023-08-14 |
| 2021-12-31 | -$33.11M 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |